Effective dose 50% (ED50) = the mean population dose necessary to achieve half the maximum (Emax) possible hypoglycaemic effect was based on published dose response data.
Being antagonists, the mid-part of the dose-benefit curve plateaus, but in contrast, a wide range of adverse events continue to increase.